Clinical Trial Update: SYMPROVE III: Health Services Research Study for Treatment of the Moderate and Severe Acute Exacerbations of Chronic Bronchitis (AECB)

View source ↗

Summary

SYMPROVE III is a health services research trial sponsored by Bayer evaluating treatment during moderate to severe acute exacerbations of chronic bronchitis. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis

Snippet

Sponsor: Bayer | Conditions: Chronic Bronchitis | Status: COMPLETED